We're working to fix a technical issue causing problems with our broadcasts. We'll have it resolved as soon as possible. We apologize for the inconvenience.
The U.S. Food and Drug Administration has given emergency use authorization for monoclonal antibody treatment for mild-to-moderate COVID-19 cases in people who have tested positive for the virus and who are at high risk of having a severe case.